Chimeric Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Chimeric Therapeutics Ltd
Access all reports
Chimeric Therapeutics Ltd is a biotechnology company focused on developing cell therapy treatments for cancer. The company specializes in chimeric antigen receptor T-cell (CAR-T) therapies, aiming to harness the immune system to target solid tumors and hematologic malignancies. The company is headquartered in Melbourne, Australia, and its shares are listed on the ASX.
Key slides for Chimeric Therapeutics Ltd
Investor Presentation
Chimeric Therapeutics Ltd
Investor Presentation
Chimeric Therapeutics Ltd
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
CHM
Country
🇦🇺 Australia